Adtalem Global Education (NYSE:CVSA) SVP Sells $330,094.26 in Stock

Adtalem Global Education Inc. (NYSE:CVSA) SVP Douglas Beck sold 2,439 shares of the company’s stock in a transaction on Wednesday, July 8th. The stock was sold at an average price of $135.34, for a total value of $330,094.26. Following the transaction, the senior vice president directly owned 33,070 shares in the company, valued at $4,475,693.80. This represents a 6.87% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Performance

NYSE:CVSA traded down $0.68 during trading hours on Friday, hitting $130.64. The company’s stock had a trading volume of 301,004 shares, compared to its average volume of 347,922. Adtalem Global Education Inc. has a 52-week low of $86.97 and a 52-week high of $156.26. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.70 and a quick ratio of 0.70. The company has a 50-day moving average price of $124.72. The firm has a market capitalization of $4.45 billion, a P/E ratio of 20.35, a PEG ratio of 0.99 and a beta of 0.62.

Adtalem Global Education (NYSE:CVSA) last issued its earnings results on Thursday, May 7th. The company reported $1.98 EPS for the quarter, topping the consensus estimate of $1.73 by $0.25. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The company had revenue of $487.03 million for the quarter. During the same quarter in the previous year, the firm posted $1.92 earnings per share. Adtalem Global Education’s revenue for the quarter was up 4.5% on a year-over-year basis. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, analysts predict that Adtalem Global Education Inc. will post 8.04 EPS for the current fiscal year.

Wall Street Analyst Weigh In

CVSA has been the topic of several recent analyst reports. Truist Financial upped their target price on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, May 11th. Wall Street Zen upgraded shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research report on Saturday, June 13th. Weiss Ratings reissued a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Barrington Research restated an “outperform” rating and issued a $170.00 price target on shares of Adtalem Global Education in a report on Monday, June 8th. Finally, Zacks Research downgraded Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 25th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.